New Strong Buy Stocks for January 14th

Here are five stocks added to the Zacks Rank #1 (Strong Buy) List today:

Brainsway BWAY: This commercial stage medical device company which is focused on the development and sale of non-invasive neuromodulation products, has seen the Zacks Consensus Estimate for its current year earnings increasing 60% over the last 60 days.

Grupo Televisa TV: This media company which is the largest in the Spanish-speaking world, and a major player in the international entertainment business, has seen the Zacks Consensus Estimate for its current year earnings increasing 22.2% over the last 60 days.

ICU Medical ICUI: This company which develops, manufactures and sells innovative medical devices used in vascular therapy, oncology and critical care applications, has seen the Zacks Consensus Estimate for its current year earnings increasing 7.7% over the last 60 days.

Sally Beauty SBH: This company which, is an international specialty retailer and distributor of professional beauty supplies, has seen the Zacks Consensus Estimate for its current year earnings increasing 6.3% over the last 60 day.

PHINIA Inc. PHIN: This company which is a premium solutions and components provider of manufacturing expertise, has seen the Zacks Consensus Estimate for its current year earnings increasing 5.2% over the last 60 days.

You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

Free: 5 Stocks to Buy As Infrastructure Spending Soars

Trillions of dollars in Federal funds have been earmarked to repair and upgrade America’s infrastructure. In addition to roads and bridges, this flood of cash will pour into AI data centers, renewable energy sources and more.

In, you’ll discover 5 surprising stocks positioned to profit the most from the spending spree that’s just getting started in this space.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

To read this article on Zacks.com click here.

Zacks Investment Research